Sr.,term,relevant,retrieved_our,True Positive (TP),False Positive (FP),False Negative (FN),Precision,Recall,time
1,tubulin alpha 1a,69,69,60,0,9,0.869565217,0.769230769,1
2,"phosphofructokinase, muscle",30,60,30,30,0,0.5,1,3
3,"Hydatidiform Mole, Partial",38,38,35,0,3,0.921052632,0.853658537,2
4,Drug withdrawal syndrome,13,13,12,0,1,0.923076923,0.857142857,1
5,"CHARCOT-MARIE-TOOTH DISEASE, TYPE 4A (disorder)",11,11,9,0,2,0.818181818,0.692307692,1
6,Prostate carcinoma,16608,16608,16000,0,608,0.963391137,0.92936803,15
7,endogenous retrovirus group K member 20,717,717,700,0,17,0.976290098,0.953678474,3
8,Penis carcinoma,23,23,17,0,6,0.739130435,0.586206897,1
9,interferon lambda 2,19,19,15,0,4,0.789473684,0.652173913,1
10,transcription factor 12,22,506,22,484,0,0.043478261,1,3
11,AIDS-Related Non-Hodgkin Lymphoma,11,11,10,0,1,0.909090909,0.833333333,1
12,protein-L-isoaspartate (D-aspartate) O-methyltransferase,17,46,17,29,0,0.369565217,1,1
13,NCK associated protein 1,16,19,16,3,0,0.842105263,1,1
14,kallikrein related peptidase 4,216,216,205,0,11,0.949074074,0.9030837,1
15,Dyggve-Melchior-Clausen syndrome,14,14,12,0,2,0.857142857,0.75,1
16,branched chain amino acid transaminase 1,19,19,11,0,8,0.578947368,0.407407407,7
17,Posterior urethral valves,12,12,9,0,3,0.75,0.6,1
18,nucleotide binding oligomerization domain containing 2,2054,2054,2000,0,54,0.973709834,0.948766603,3
19,sorting nexin 9,13,26,13,13,0,0.5,1,0
20,Pulmonary Alveolar Proteinosis,107,110,93,3,14,0.845454545,0.768595041,1
21,fructosamine 3 kinase,12,26,12,14,0,0.461538462,1,3
22,secretoglobin family 2A member 2,108,108,99,0,9,0.916666667,0.846153846,1
23,Hurler-Scheie Syndrome,22,22,14,0,8,0.636363636,0.466666667,1
24,syntaxin 16,20,40,20,20,0,0.5,1,3
25,fibronectin type III and SPRY domain containing 1 like,160,160,150,0,10,0.9375,0.882352941,1
26,AICARDI-GOUTIERES SYNDROME,68,273,68,205,0,0.249084249,1,1
27,Stage III Colorectal Cancer,14,25,14,11,0,0.56,1,0
28,RAPP-HODGKIN SYNDROME,49,49,40,0,9,0.816326531,0.689655172,1
29,adenosine deaminase RNA specific,133,198,133,65,0,0.671717172,1,3
30,"Bronchiolitis, Viral",237,237,223,0,14,0.94092827,0.888446215,1
31,Adamantinous Craniopharyngioma,12,12,11,0,1,0.916666667,0.846153846,1
32,Peripheral Neuropathy,673,678,660,5,13,0.973451327,0.962099125,1
33,Sebaceous Adenocarcinoma,38,38,33,0,5,0.868421053,0.76744186,0
34,"Neoplasms, Intracranial",78,78,72,0,6,0.923076923,0.857142857,0
35,Nemaline myopathy 3,13,13,12,0,1,0.923076923,0.857142857,1
36,Cerebral Aneurysm,38,38,29,0,9,0.763157895,0.617021277,1
37,Greig cephalopolysyndactyly syndrome,71,71,66,0,5,0.929577465,0.868421053,1
38,Crescentic Glomerulonephritis,50,50,47,0,3,0.94,0.886792453,0
39,Inverted Papilloma,41,41,37,0,4,0.902439024,0.822222222,0
40,Periapical Granuloma,13,13,13,0,0,1,1,1
41,Ovarian Diseases,700,700,687,0,13,0.981428571,0.963534362,2
42,"Alport Syndrome, X-Linked",105,105,100,0,5,0.952380952,0.909090909,0
43,kallikrein related peptidase 12,20,20,12,0,8,0.6,0.428571429,1
44,CROUZON SYNDROME WITH ACANTHOSIS NIGRICANS (disorder),14,14,11,0,3,0.785714286,0.647058824,1
45,Color blindness,26,39,26,13,0,0.666666667,1,1
46,lymphotoxin alpha,985,1970,985,985,0,0.5,1,9
47,metal regulatory transcription factor 1,11,305,11,294,0,0.036065574,1,3
48,Anemia of chronic disease,62,62,58,0,4,0.935483871,0.878787879,1
49,NOTCH1 [plasma membrane],18,18,15,0,3,0.833333333,0.714285714,0
50,Complex Regional Pain Syndromes,11,11,11,0,0,1,1,1
51,talin 1,20,40,20,20,0,0.5,1,3
52,Sessile Serrated Adenoma/Polyp,45,45,42,0,3,0.933333333,0.875,0
53,Thrombocytopenic purpura,20,24,20,4,0,0.833333333,1,1
54,Bacteroides fragilis infection in conditions classified elsewhere and of unspecified site,19,19,19,0,0,1,1,1
55,microtubule affinity regulating kinase 4,11,11,11,0,0,1,1,1
56,Stable angina,143,143,135,0,8,0.944055944,0.894039735,1
57,Meningeal Carcinomatosis,16,16,13,0,3,0.8125,0.684210526,0
58,Atypical Ductal Breast Hyperplasia,35,35,35,0,0,1,1,0
59,ganglioside induced differentiation associated protein 1,144,288,144,144,0,0.5,1,1
60,cyclin A1,119,238,119,119,0,0.5,1,3
61,DNA Damage,327,5263,327,4936,0,0.062131864,1,13
62,NOTCH2 [plasma membrane],12,12,11,0,1,0.916666667,0.846153846,1
63,fibrinogen like 2,24,24,24,0,0,1,1,1
64,Prenatal Exposure Delayed Effects,82,82,74,0,8,0.902439024,0.822222222,1
65,syntaxin binding protein 2,19,38,19,19,0,0.5,1,1
66,Virchow's node (disorder),14,14,11,0,3,0.785714286,0.647058824,0
67,"Liver Cirrhosis, Experimental",286,286,266,0,20,0.93006993,0.869281046,1
68,kininogen 1,261,522,261,261,0,0.5,1,2
69,Diabetic Nephropathy,2181,2222,2000,41,181,0.900090009,0.846740051,33
70,Epidermolysis Bullosa Simplex Kobner,29,29,25,0,4,0.862068966,0.757575758,1
71,histatin 3,23,46,23,23,0,0.5,1,2
72,Cholestatic liver disease,34,34,30,0,4,0.882352941,0.789473684,0
73,septin 9,146,292,146,146,0,0.5,1,3
74,Anthrax disease,63,63,55,0,8,0.873015873,0.774647887,1
75,ATP/GTP binding protein like 2,14,14,14,0,0,1,1,0
76,Classical galactosemia,120,120,98,0,22,0.816666667,0.690140845,1
77,Renal tubular acidosis,43,117,43,74,0,0.367521368,1,1
78,Antisocial behavior,140,141,135,1,5,0.957446809,0.931034483,1
79,Myxoid/Round Cell Liposarcoma,36,36,36,0,0,1,1,0
80,nuclear factor of activated T cells 5,23,23,16,0,7,0.695652174,0.533333333,1
81,Pena-Shokeir syndrome type I,11,11,11,0,0,1,1,1
82,Fanconi Anemia,1157,8321,1157,7164,0,0.139045788,1,30
83,formimidoyltransferase cyclodeaminase,19,38,19,19,0,0.5,1,3
84,"Colitis, Collagenous",18,18,15,0,3,0.833333333,0.714285714,1
85,fungal keratitis,14,14,11,0,3,0.785714286,0.647058824,1
86,L-2-HYDROXYGLUTARIC ACIDURIA,13,13,13,0,0,1,1,1
87,transcription elongation regulator 1 like,14,14,14,0,0,1,1,1
88,Origin recognition complex subunit 4,11,313,11,302,0,0.03514377,1,3
89,Isovaleryl-CoA dehydrogenase deficiency,70,70,63,0,7,0.9,0.818181818,1
90,sushi repeat containing protein X-linked 2,38,38,33,0,5,0.868421053,0.76744186,1
91,"protein C, inactivator of coagulation factors Va and VIIIa",2389,2389,2000,0,389,0.837170364,0.719942405,4
92,family with sequence similarity 126 member A,615,615,600,0,15,0.975609756,0.952380952,1
93,Congenital amegakaryocytic thrombocytopenia,32,32,21,0,11,0.65625,0.488372093,1
94,Anxiety Disorders,1137,1137,1000,0,137,0.879507476,0.784929356,2
95,pricking of skin,41,41,38,0,3,0.926829268,0.863636364,1
96,Transient Ischemic Attack,263,263,260,0,3,0.988593156,0.977443609,1
97,aldo-keto reductase family 1 member C1,50,488,50,438,0,0.102459016,1,5
98,High Grade Cervical Intraepithelial Neoplasia,42,42,37,0,5,0.880952381,0.787234043,1
99,Kearns-Sayre syndrome,19,19,19,0,0,1,1,0
100,Cutaneous Melanoma,677,677,644,0,33,0.951255539,0.907042254,2
101,Chronic Obstructive Airway Disease,2296,2296,2000,0,296,0.871080139,0.771604938,3
102,tubulin beta 2B class IIb,30,30,24,0,6,0.8,0.666666667,1
103,Chronic Glomerulonephritis,21,21,19,0,2,0.904761905,0.826086957,1
104,phosphoglycerate dehydrogenase,110,224,110,114,0,0.491071429,1,3
105,Robinow Syndrome,45,67,45,22,0,0.671641791,1,1
106,Common Migraine,117,117,107,0,10,0.914529915,0.842519685,1
107,Thyroid associated opthalmopathies,231,231,212,0,19,0.917748918,0.848,1
108,caspase 5,34,68,34,34,0,0.5,1,1
109,cyclin dependent kinase inhibitor 1C,436,436,400,0,36,0.917431193,0.847457627,2
110,tubulin beta 1 class VI,15,15,15,0,0,1,1,0
111,myosin heavy chain 7,339,352,339,13,0,0.963068182,1,1
112,fibroblast activation protein alpha,212,212,190,0,22,0.896226415,0.811965812,2
113,"membrane bound transcription factor peptidase, site 2",86,86,80,0,6,0.930232558,0.869565217,1
114,glycerol kinase,68,739,68,671,0,0.092016238,1,4
115,"Foramen Ovale, Patent",27,27,22,0,5,0.814814815,0.6875,1
116,Ethylmalonic encephalopathy,25,52,25,27,0,0.480769231,1,1
117,cytotoxic T-lymphocyte associated protein 4,2058,2058,2000,0,58,0.971817298,0.945179584,3
118,NIMA related kinase 1,20,29,20,9,0,0.689655172,1,1
119,endothelin 1,1111,2222,1111,1111,0,0.5,1,7
120,Pigmentation Disorders,14,14,11,0,3,0.785714286,0.647058824,1
121,"protein phosphatase, Mg2+/Mn2+ dependent 1D",146,146,124,0,22,0.849315068,0.738095238,1
122,"Paraparesis, Spastic",108,108,99,0,9,0.916666667,0.846153846,1
123,Perivascular Epithelioid Cell Neoplasms,36,36,29,0,7,0.805555556,0.674418605,0
124,tau tubulin kinase 2,22,44,22,22,0,0.5,1,0
125,idiopathic hypercalciuria,18,18,16,0,2,0.888888889,0.8,0
126,protein phosphatase 1 regulatory inhibitor subunit 1B,100,100,93,0,7,0.93,0.869158879,1
127,Prolapsed lumbar disc,17,17,17,0,0,1,1,0
128,claudin 16,77,154,77,77,0,0.5,1,1
129,NOONAN-LIKE/MULTIPLE GIANT CELL LESION SYNDROME (disorder),11,11,9,0,2,0.818181818,0.692307692,0
130,"BRACHYDACTYLY, TYPE B1",35,35,33,0,2,0.942857143,0.891891892,1
131,"POLYMICROGYRIA, BILATERAL FRONTOPARIETAL",26,26,22,0,4,0.846153846,0.733333333,1
132,reticulon 2,12,24,12,12,0,0.5,1,1
133,Nuclear receptor subfamily 1 group D member 1,96,514,96,418,0,0.186770428,1,3
134,Nodular glomerulosclerosis,21,21,18,0,3,0.857142857,0.75,1
135,regulatory factor X associated ankyrin containing protein,16,16,16,0,0,1,1,0
136,NADH:Q(1) Oxidoreductase deficiency,20,20,20,0,0,1,1,1
137,Congenital neurologic anomalies,23,23,20,0,3,0.869565217,0.769230769,1
138,WW domain containing E3 ubiquitin protein ligase 2,11,20,11,9,0,0.55,1,1
139,Colorectal Neoplasms,3181,3181,3000,0,181,0.943099654,0.892325996,3
140,transcription factor 3,122,244,122,122,0,0.5,1,1
141,T-Cell Prolymphocytic Leukemia,102,102,98,0,4,0.960784314,0.924528302,1
142,chromogranin A,392,784,392,392,0,0.5,1,8
143,Fetal Growth Retardation,180,180,160,0,20,0.888888889,0.8,1
144,"Muscular Dystrophies, Limb-Girdle",505,505,499,0,6,0.988118812,0.976516634,1
145,von Willebrand Disease,459,847,459,388,0,0.541912633,1,2
146,angiopoietin 2,494,988,494,494,0,0.5,1,3
147,GIPC PDZ domain containing family member 3,19,19,12,0,7,0.631578947,0.461538462,1
148,Epidermolysis Bullosa Herpetiformis Dowling-Meara,29,29,25,0,4,0.862068966,0.757575758,1
149,inflammatory joint disease,19,19,19,0,0,1,1,0
150,Duodenal Neoplasms,15,15,13,0,2,0.866666667,0.764705882,1
151,desmoglein 4,34,68,34,34,0,0.5,1,2
152,"Meningioma, benign, no ICD-O subtype",388,388,365,0,23,0.940721649,0.888077859,1
153,Intraepithelial Neoplasia,225,225,211,0,14,0.937777778,0.882845188,1
154,"Rhinitis, Allergic, Perennial",45,45,36,0,9,0.8,0.666666667,1
155,"STICKLER SYNDROME, TYPE II (disorder)",13,13,11,0,2,0.846153846,0.733333333,0
156,complex iii deficiency,22,22,21,0,1,0.954545455,0.913043478,1
157,microRNA 330,15,30,15,15,0,0.5,1,1
158,insulin like growth factor binding protein 3,911,911,900,0,11,0.987925357,0.976138829,2
159,Coronary Stenosis,156,156,121,0,35,0.775641026,0.633507853,1
160,Polycystic Kidney Diseases,366,366,344,0,22,0.93989071,0.886597938,1
161,"Neoplasms, Multiple Primary",36,36,32,0,4,0.888888889,0.8,1
162,nitric oxide,35,12713,35,12678,0,0.002753087,1,29
163,Wasting Syndrome,13,13,13,0,0,1,1,1
164,H2.0 like homeobox,27,27,23,0,4,0.851851852,0.741935484,1
165,Ovarian failure,84,724,84,640,0,0.116022099,1,3
166,vasodilator stimulated phosphoprotein,30,30,29,0,1,0.966666667,0.935483871,0
167,nuclear receptor subfamily 4 group A member 3,206,509,206,303,0,0.404715128,1,5
168,prokineticin 2,74,148,74,74,0,0.5,1,3
169,Vitamin A Deficiency,27,27,22,0,5,0.814814815,0.6875,1
170,interleukin 25,61,122,61,61,0,0.5,1,3
171,Bile Duct Neoplasms,20,20,19,0,1,0.95,0.904761905,1
172,Torre-Muir syndrome,93,93,88,0,5,0.946236559,0.897959184,1
173,sulfite oxidase,25,409,25,384,0,0.061124694,1,6
174,Pelger-Huet Anomaly,20,20,14,0,6,0.7,0.538461538,0
175,uroporphyrinogen III synthase,70,140,70,70,0,0.5,1,1
176,glycine receptor alpha 1,120,120,104,0,16,0.866666667,0.764705882,1
177,IgA nephropathy,150,306,150,156,0,0.490196078,1,4
178,bromodomain adjacent to zinc finger domain 1B,18,18,18,0,0,1,1,0
179,Congenital cataract,192,198,192,6,0,0.96969697,1,1
180,myosin IXB,105,210,105,105,0,0.5,1,1
181,"Depressive episode, unspecified",22,22,17,0,5,0.772727273,0.62962963,1
182,Middle Ear Cholesteatoma,16,16,14,0,2,0.875,0.777777778,1
183,Secondary malignant neoplasm of skin,13,13,13,0,0,1,1,1
184,Hartnup Disease,102,102,95,0,7,0.931372549,0.871559633,1
185,Pancreatic adenocarcinoma,596,596,500,0,96,0.838926174,0.722543353,1
186,Seckel syndrome,67,71,67,4,0,0.943661972,1,1
187,N-acetyltransferase 1,369,1001,369,632,0,0.368631369,1,3
188,Alveolar Bone Loss,75,75,67,0,8,0.893333333,0.807228916,1
189,basic helix-loop-helix family member e41,49,49,43,0,6,0.87755102,0.781818182,1
190,Reperfusion Injury,470,470,395,0,75,0.840425532,0.724770642,1
191,Chronic rejection of renal transplant,57,57,55,0,2,0.964912281,0.93220339,1
192,phosphodiesterase 7B,12,24,12,12,0,0.5,1,0
193,microtubule associated protein tau,2277,2277,2000,0,277,0.878348704,0.783085356,3
194,syntaxin 1A,92,175,92,83,0,0.525714286,1,3
195,Sinus Node Dysfunction (disorder),29,29,28,0,1,0.965517241,0.933333333,1
196,ubiquitin specific peptidase 9 X-linked,40,40,33,0,7,0.825,0.70212766,1
197,HAND DERMATITIS,12,12,12,0,0,1,1,0
198,NEDD4 like E3 ubiquitin protein ligase,62,62,62,0,0,1,1,1
199,Alstrom Syndrome,41,957,41,916,0,0.042842215,1,2
200,Mixed Oligodendroglioma-Astrocytoma,32,32,29,0,3,0.90625,0.828571429,1
201,Reticular dysgenesis,11,11,8,0,3,0.727272727,0.571428571,1
202,Irritable Bowel Syndrome,345,345,300,0,45,0.869565217,0.769230769,1
203,lysosomal associated membrane protein 3,84,84,76,0,8,0.904761905,0.826086957,1
204,protein phosphatase 1 regulatory subunit 12C,19,648,19,629,0,0.029320988,1,6
205,SLIT-ROBO Rho GTPase activating protein 2,18,36,18,18,0,0.5,1,0
206,child abuse behavior,25,25,22,0,3,0.88,0.785714286,1
207,MYELODYSPLASTIC SYNDROME,925,1240,925,315,0,0.745967742,1,2
208,"Granular Dystrophy, Corneal",20,20,17,0,3,0.85,0.739130435,1
209,Hand foot uterus syndrome,25,25,21,0,4,0.84,0.724137931,1
210,Autosomal Dominant Parkinsonism,26,26,19,0,7,0.730769231,0.575757576,0
211,Congenital infectious disease,12,12,11,0,1,0.916666667,0.846153846,1
212,Kruppel-like factor 5,30,163,30,133,0,0.18404908,1,3
213,Adenomatous Polyps,129,129,99,0,30,0.76744186,0.622641509,1
214,transition protein 1,12,24,12,12,0,0.5,1,1
215,Tardive Dyskinesia,234,234,221,0,13,0.944444444,0.894736842,1
216,cysteine rich with EGF like domains 1,36,36,32,0,4,0.888888889,0.8,1
217,Romano-Ward Syndrome,85,85,79,0,6,0.929411765,0.868131868,0
218,Cocaine-Related Disorders,259,259,211,0,48,0.814671815,0.687296417,1
219,TAK1 complex [cytosol],14,14,12,0,2,0.857142857,0.75,1
220,Shprintzen syndrome,224,224,200,0,24,0.892857143,0.806451613,1
221,gap junction protein alpha 4,106,106,99,0,7,0.933962264,0.876106195,1
222,TGF-beta activated kinase 1 (MAP3K7) binding protein 2,22,22,22,0,0,1,1,0
223,ADAM metallopeptidase with thrombospondin type 1 motif 5,60,60,54,0,6,0.9,0.818181818,0
224,Solute carrier family 22 member 17,14,426,14,412,0,0.03286385,1,1
225,Sudden infant death syndrome,286,286,231,0,55,0.807692308,0.677419355,1
226,Hepatosplenic T-Cell Lymphoma,11,11,11,0,0,1,1,0
227,Alcohol abuse,221,221,200,0,21,0.904977376,0.826446281,1
228,actin filament associated protein 1 like 2,11,11,7,0,4,0.636363636,0.466666667,1
229,ankyrin 3,124,248,124,124,0,0.5,1,1
230,Neurofibromatosis-Noonan syndrome,23,23,21,0,2,0.913043478,0.84,1
231,myosin XVIIIB,27,54,27,27,0,0.5,1,1
232,Intestinal Pseudo-Obstruction,21,21,19,0,2,0.904761905,0.826086957,1
233,MAPKs [cytosol],18,18,17,0,1,0.944444444,0.894736842,0
234,"Aplastic anemia, idiopathic",12,12,7,0,5,0.583333333,0.411764706,1
235,PTEN Hamartoma Tumor Syndrome,30,31,28,1,2,0.903225806,0.875,1
236,Neurotoxicity Syndromes,42,42,39,0,3,0.928571429,0.866666667,1
237,dynein axonemal heavy chain 8,772,772,700,0,72,0.906735751,0.829383886,2
238,Ichthyosis Bullosa of Siemens,186,186,122,0,64,0.655913978,0.488,1
239,contactin 6,19,38,19,19,0,0.5,1,3
240,Swyer Syndrome,26,26,26,0,0,1,1,0
241,Hyperimmunoglobulin M syndrome,96,96,80,0,16,0.833333333,0.714285714,1
242,"stage, non-small cell lung cancer",75,75,72,0,3,0.96,0.923076923,1
243,Ichthyosis Vulgaris,81,81,78,0,3,0.962962963,0.928571429,1
244,Pfaundler-Hurler Syndrome,71,71,65,0,6,0.915492958,0.844155844,1
245,neurobeachin like 2,24,24,22,0,2,0.916666667,0.846153846,1
246,oxidative stress responsive serine rich 1,15,15,10,0,5,0.666666667,0.5,1
247,"POPLITEAL PTERYGIUM SYNDROME, LETHAL TYPE",14,14,13,0,1,0.928571429,0.866666667,0
248,aldo-keto reductase family 1 member B10,115,476,115,361,0,0.241596639,1,1
249,"Plaque, Amyloid",639,639,600,0,39,0.938967136,0.884955752,1
250,myosin VIIA,207,426,207,219,0,0.485915493,1,3
251,Cystic Kidney Diseases,50,50,48,0,2,0.96,0.923076923,1
252,Van Buchem disease,23,26,23,3,0,0.884615385,1,1
253,Mood Disorders,831,831,800,0,31,0.962695548,0.928074246,1
254,"Carcinoma, Spindle-Cell",30,30,27,0,3,0.9,0.818181818,0
255,Pediatric Obesity,96,96,87,0,9,0.90625,0.828571429,0
256,Protein disulfide-isomerase,11,4350,11,4339,0,0.002528736,1,15
257,ectodysplasin A receptor,62,124,62,62,0,0.5,1,3
258,Respiratory distress,57,635,57,578,0,0.08976378,1,5
259,21-hydroxylase deficiency,248,248,221,0,27,0.891129032,0.803636364,1
260,hexose-6-phosphate dehydrogenase/glucose 1-dehydrogenase,59,59,43,0,16,0.728813559,0.573333333,0
261,Liver Cirrhosis,1933,2460,1933,527,0,0.785772358,1,3
262,Non-Functioning Pituitary Gland Neoplasm,12,12,5,0,7,0.416666667,0.263157895,0
263,Oropharyngeal Neoplasms,27,27,25,0,2,0.925925926,0.862068966,0
264,Partial Trisomy,61,61,57,0,4,0.93442623,0.876923077,0
265,interleukin 12 receptor subunit beta 1,115,115,100,0,15,0.869565217,0.769230769,1
266,serine/threonine kinase 3,18,231,18,213,0,0.077922078,1,3
267,Hypokalemic alkalosis,12,12,11,0,1,0.916666667,0.846153846,1
268,"glucosidase alpha, acid",479,479,400,0,79,0.835073069,0.716845878,1
269,cervical cancer squamous cell,18,18,15,0,3,0.833333333,0.714285714,1
270,Action Myoclonus-Renal Failure Syndrome,13,13,11,0,2,0.846153846,0.733333333,0
271,CCAAT enhancer binding protein delta,79,79,63,0,16,0.797468354,0.663157895,1
272,protein tyrosine phosphatase receptor type K,23,23,22,0,1,0.956521739,0.916666667,1
273,"LACTOSE INTOLERANCE, ADULT TYPE",29,29,25,0,4,0.862068966,0.757575758,1
274,Split hand foot deformity 1,112,112,98,0,14,0.875,0.777777778,1
275,vitamin K epoxide reductase complex subunit 1,203,946,203,743,0,0.214587738,1,8
276,insulin like growth factor 2 mRNA binding protein 3,88,88,80,0,8,0.909090909,0.833333333,1
277,Hypoplasia of corpus callosum,14,14,14,0,0,1,1,0
278,Type I Mucolipidosis,58,58,53,0,5,0.913793103,0.841269841,0
279,myelin protein zero like 1,13,13,13,0,0,1,1,1
280,Jervell-Lange Nielsen Syndrome,75,75,71,0,4,0.946666667,0.898734177,1
281,glycoprotein IX platelet,86,86,79,0,7,0.918604651,0.849462366,1
282,Colonic Polyps,109,109,91,0,18,0.834862385,0.716535433,1
283,Lytic lesion,23,23,19,0,4,0.826086957,0.703703704,1
284,"Hemorrhagic Fever, Ebola",31,31,29,0,2,0.935483871,0.878787879,1
285,Ovarian Clear Cell Adenocarcinoma,28,28,21,0,7,0.75,0.6,1
286,Benign Meningioma,27,27,26,0,1,0.962962963,0.928571429,1
287,Xenograft Model,887,887,800,0,87,0.901916573,0.821355236,1
288,R-spondin 2,13,26,13,13,0,0.5,1,1
289,Ovarian Hyperstimulation Syndrome,104,104,96,0,8,0.923076923,0.857142857,1
290,solute carrier family 38 member 1,694,695,680,1,14,0.978417266,0.960451977,2
291,beclin 1,304,916,304,612,0,0.331877729,1,3
292,Hairy Cell Leukemia,251,256,251,5,0,0.98046875,1,1
293,codanin 1,47,94,47,47,0,0.5,1,8
294,Glycogen Storage Disease Type VII,26,29,22,3,4,0.75862069,0.733333333,0
295,"Chromosome 10, monosomy 10q",15,15,15,0,0,1,1,1
296,"Tuberculosis, Pulmonary",851,851,833,0,18,0.978848414,0.958573072,1
297,succinic semialdehyde,12,31,12,19,0,0.387096774,1,1
298,Meningococcal meningitis,24,24,22,0,2,0.916666667,0.846153846,0
299,calcium/calmodulin dependent protein kinase II alpha,22,22,20,0,2,0.909090909,0.833333333,1
300,"Myoclonic Epilepsy, Juvenile",160,162,156,2,4,0.962962963,0.951219512,1
301,ANOPHTHALMIA AND PULMONARY HYPOPLASIA,13,13,11,0,2,0.846153846,0.733333333,1
302,Tumor Expansion,26,26,21,0,5,0.807692308,0.677419355,0
303,angiopoietin like 2,75,75,69,0,6,0.92,0.851851852,1
304,DDB1 and CUL4 associated factor 6,29,58,29,29,0,0.5,1,3
305,Brain Neoplasms,1614,1614,1434,0,180,0.888475836,0.799331104,3
306,Ventricular Dysfunction,19,110,19,91,0,0.172727273,1,0
307,vesicle associated membrane protein 3,11,11,11,0,0,1,1,1
308,Mature Teratoma,13,13,13,0,0,1,1,1
309,chronic urticaria,25,25,22,0,3,0.88,0.785714286,0
310,Primary Carcinoma,64,64,60,0,4,0.9375,0.882352941,1
311,Uterine Corpus Sarcoma,20,20,19,0,1,0.95,0.904761905,1
312,Kruppel like factor 5,133,133,122,0,11,0.917293233,0.847222222,1
313,protein tyrosine phosphatase receptor type A,93,93,87,0,6,0.935483871,0.878787879,0
314,Immune thrombocytopenic purpura,255,255,232,0,23,0.909803922,0.834532374,1
315,nescient helix-loop-helix 1,63,63,57,0,6,0.904761905,0.826086957,0
316,Animal Mammary Neoplasms,405,405,399,0,6,0.985185185,0.97080292,1
317,"LEBER CONGENITAL AMAUROSIS, TYPE II (disorder)",15,15,13,0,2,0.866666667,0.764705882,0
318,"Liposarcoma, Dedifferentiated",80,80,73,0,7,0.9125,0.83908046,1
319,"Obesity, Abdominal",175,175,166,0,9,0.948571429,0.902173913,1
320,"Eye Diseases, Hereditary",11,11,9,0,2,0.818181818,0.692307692,0
321,"Epilepsy, Myoclonic, Infantile",12,12,12,0,0,1,1,1
322,CCAAT enhancer binding protein zeta,54,54,47,0,7,0.87037037,0.770491803,1
323,Neuroblastic Tumor,13,13,11,0,2,0.846153846,0.733333333,1
324,Adenocarcinoma of colon,367,367,345,0,22,0.940054496,0.88688946,1
325,Parathyroid Gland Adenocarcinoma,117,117,110,0,7,0.94017094,0.887096774,0
326,Apolipoprotein E,8737,17836,8737,9099,0,0.489851985,1,24
327,"BH3-like motif containing, cell death inducer",11,22,11,11,0,0.5,1,0
328,"Spastic paraplegia 4, autosomal dominant",31,31,29,0,2,0.935483871,0.878787879,1
329,sarcoglycan gamma,334,334,300,0,34,0.898203593,0.815217391,2
330,Bardet-Biedl syndrome 4,44,497,44,453,0,0.088531187,1,5
331,cyclin dependent kinase 2 associated protein 2,53,53,43,0,10,0.811320755,0.682539683,0
332,protein kinase C eta,70,522,70,452,0,0.134099617,1,15
333,Hypopigmentation disorder,110,110,96,0,14,0.872727273,0.774193548,1
334,"THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL DOMINANT",23,23,22,0,1,0.956521739,0.916666667,0
335,CHROMOSOME 8p11 MYELOPROLIFERATIVE SYNDROME,15,15,13,0,2,0.866666667,0.764705882,1
336,"Sarcoma, Epithelioid",48,48,45,0,3,0.9375,0.882352941,1
337,metastatic osteosarcoma,26,26,26,0,0,1,1,1
338,"Hyperoxaluria, Primary",27,31,27,4,0,0.870967742,1,1
339,cyclin A2,145,290,145,145,0,0.5,1,3
340,Endemic Cretinism,272,272,254,0,18,0.933823529,0.875862069,0
341,Vulval intraepithelial neoplasia,51,51,49,0,2,0.960784314,0.924528302,1
342,Craniofrontonasal dysplasia,31,31,31,0,0,1,1,0
343,"Muscular Atrophy, Spinal, Type II",16,16,16,0,0,1,1,0
344,G protein-coupled receptor 55,20,40,20,20,0,0.5,1,1
345,follistatin like 1,56,56,45,0,11,0.803571429,0.671641791,1
346,Complete Hearing Loss,48,48,43,0,5,0.895833333,0.811320755,1
347,G protein-coupled receptor 35,11,22,11,11,0,0.5,1,0
348,"Nephrogenic Diabetes Insipidus, Type I",184,201,184,17,0,0.915422886,1,1
349,orbit (eye disorders),29,29,27,0,2,0.931034483,0.870967742,0
350,COPPER-OVERLOAD CIRRHOSIS,11,11,11,0,0,1,1,1
351,coenzyme A,472,542,472,70,0,0.870848708,1,1
352,AIDS-Related Opportunistic Infections,18,18,15,0,3,0.833333333,0.714285714,0
353,microRNA 146a,549,1098,549,549,0,0.5,1,8
354,Paroxysmal nocturnal hemoglobinuria,341,341,321,0,20,0.941348974,0.889196676,1
355,Tongue Neoplasms,46,46,44,0,2,0.956521739,0.916666667,1
356,"ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 1",81,81,76,0,5,0.938271605,0.88372093,0
357,Stage 4S neuroblastoma,48,48,43,0,5,0.895833333,0.811320755,1
358,ISG15 ubiquitin like modifier,101,101,91,0,10,0.900990099,0.81981982,1
359,Gingival Hemorrhage,12,12,12,0,0,1,1,0
360,advanced glycosylation end-product specific receptor,407,407,380,0,27,0.933660934,0.875576037,2
361,Exonuclease 1,80,968,80,888,0,0.082644628,1,2
362,class II major histocompatibility complex transactivator,154,154,121,0,33,0.785714286,0.647058824,1
363,solute carrier family 22 member 23,14,395,14,381,0,0.035443038,1,5
364,Tn antigens [Golgi lumen],12,12,12,0,0,1,1,0
365,"Chondrodysplasia, Grebe type",12,12,12,0,0,1,1,0
366,Bartter Disease,122,122,122,0,0,1,1,1
367,TSPY like 2,43,43,39,0,4,0.906976744,0.829787234,0
368,Cervix carcinoma,3356,3356,3221,0,135,0.95977354,0.922658264,5
369,malignant fibrous histiocytoma amplified sequence 1,12,24,12,12,0,0.5,1,1
370,activity regulated cytoskeleton associated protein,41,41,37,0,4,0.902439024,0.822222222,1
371,protein phosphatase 1 regulatory inhibitor subunit 14A,11,11,11,0,0,1,1,0
372,"Carcinoma, Neuroendocrine",79,79,63,0,16,0.797468354,0.663157895,1
373,Squamous cell carcinoma of esophagus,2058,2058,1997,0,61,0.970359572,0.942425672,3
374,22q11 Deletion Syndrome,42,42,39,0,3,0.928571429,0.866666667,1
375,Japanese Encephalitis,87,87,85,0,2,0.977011494,0.95505618,0
376,"HEMATURIA, BENIGN FAMILIAL",31,31,25,0,6,0.806451613,0.675675676,1
377,cyclin dependent kinase 3,14,14,13,0,1,0.928571429,0.866666667,1
378,Hypotrichosis simplex,34,34,29,0,5,0.852941176,0.743589744,0
379,leukocyte associated immunoglobulin like receptor 1,11,11,11,0,0,1,1,1
380,"MIGRAINE, FAMILIAL HEMIPLEGIC, 2",31,31,26,0,5,0.838709677,0.722222222,0
381,CAMPTODACTYLY-ARTHROPATHY-COXA VARA-PERICARDITIS SYNDROME,13,13,11,0,2,0.846153846,0.733333333,1
382,Craniofacial Dysostosis,62,138,62,76,0,0.449275362,1,1
383,Platelet endothelial cell adhesion molecule,35,720,35,685,0,0.048611111,1,4
384,Malignant neoplasm of oropharynx,63,63,55,0,8,0.873015873,0.774647887,1
385,receptor activity modifying protein 2,29,29,29,0,0,1,1,1
386,"Malaria, Cerebral",193,198,193,5,0,0.974747475,1,1
387,Schizophrenia and related disorders,17,17,12,0,5,0.705882353,0.545454545,1
388,Speech Delay,22,22,19,0,3,0.863636364,0.76,0
389,"Hypomagnesemia 2, renal",11,11,11,0,0,1,1,1
390,calpain 10,364,728,364,364,0,0.5,1,3
391,laminin subunit alpha 4,42,42,39,0,3,0.928571429,0.866666667,1
392,Dystonia Musculorum Deformans,98,98,86,0,12,0.87755102,0.781818182,1
393,growth differentiation factor 15,358,716,358,358,0,0.5,1,9
394,Mixed Connective Tissue Disease,50,50,44,0,6,0.88,0.785714286,0
395,Severe combined immunodeficiency due to adenosine deaminase deficiency,39,39,39,0,0,1,1,0
396,hydroxysteroid 17-beta dehydrogenase 6,157,157,119,0,38,0.757961783,0.61025641,1
397,protein kinase C epsilon,81,431,81,350,0,0.187935035,1,2
398,Origin recognition complex subunit 1,38,347,38,309,0,0.109510086,1,2
399,Eye Neoplasms,17,17,15,0,2,0.882352941,0.789473684,1
400,"Cholestasis, Extrahepatic",27,27,23,0,4,0.851851852,0.741935484,0
401,CASP8 and FADD like apoptosis regulator,223,223,216,0,7,0.968609865,0.939130435,1
402,pyruvate carboxylase,252,915,252,663,0,0.275409836,1,2
403,Merkel Cell Polyomavirus Infection,12,12,11,0,1,0.916666667,0.846153846,1
404,Hereditary pancreatitis,336,336,321,0,15,0.955357143,0.914529915,1
405,Neuronal Ceroid-Lipofuscinoses,269,269,255,0,14,0.94795539,0.901060071,1
406,Arsenic Poisoning,79,79,71,0,8,0.898734177,0.816091954,0
407,"golgin, RAB6 interacting",22,22,19,0,3,0.863636364,0.76,1
408,Congenital abnormality of vein,12,12,11,0,1,0.916666667,0.846153846,0
409,calcium/calmodulin dependent serine protein kinase,65,65,63,0,2,0.969230769,0.940298507,1
410,Tumor Initiation,262,262,223,0,39,0.851145038,0.740863787,1
411,metallothionein 1H,35,180,35,145,0,0.194444444,1,3
412,"Graft Occlusion, Vascular",27,27,23,0,4,0.851851852,0.741935484,1
413,Polycythemia Vera,924,924,880,0,44,0.952380952,0.909090909,2
414,Systemic Anaplastic Large Cell Lymphoma,22,22,19,0,3,0.863636364,0.76,0
415,Excessive daytime somnolence,17,17,15,0,2,0.882352941,0.789473684,1
416,Coronary Arteriosclerosis,4010,4010,3997,0,13,0.996758105,0.993537161,4
417,epoxide hydrolase 2,117,234,117,117,0,0.5,1,2
418,cerebellar degeneration related protein 2,46,46,43,0,3,0.934782609,0.87755102,0
419,prostaglandin F2alpha,12,12,12,0,0,1,1,1
420,Diabetic foot ulcer,24,24,19,0,5,0.791666667,0.655172414,0
421,MCM2-7 [nucleoplasm],14,14,14,0,0,1,1,1
422,interferon induced protein 44,34,38,34,4,0,0.894736842,1,0
423,Laron Syndrome,208,214,208,6,0,0.971962617,1,1
424,Urinary tract infection,176,176,166,0,10,0.943181818,0.892473118,1
425,casein kinase 1 epsilon,41,41,39,0,2,0.951219512,0.906976744,0
426,TIA1 cytotoxic granule associated RNA binding protein,48,59,48,11,0,0.813559322,1,1
427,nuclear receptor subfamily 5 group A member 2,92,92,87,0,5,0.945652174,0.896907216,0
428,Prothrombin gene mutation,68,68,54,0,14,0.794117647,0.658536585,1
429,Ataxia Telangiectasia,943,943,898,0,45,0.952279958,0.908906883,1
430,cyclin dependent kinase 2,635,725,635,90,0,0.875862069,1,1
431,"MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2B",62,62,57,0,5,0.919354839,0.850746269,1
432,paired like homeodomain 3,114,114,98,0,16,0.859649123,0.753846154,1
433,"Hyperparathyroidism, Primary",298,298,255,0,43,0.855704698,0.747800587,1
434,AKT interacting protein,14,28,14,14,0,0.5,1,0
435,Rapidly Progressive Glomerulonephritis,11,11,9,0,2,0.818181818,0.692307692,1
436,protein tyrosine phosphatase receptor type T,36,36,36,0,0,1,1,1
437,Tumor Virus Infections,23,23,22,0,1,0.956521739,0.916666667,0
438,Hirschsprung disease 1,342,342,321,0,21,0.938596491,0.884297521,1
439,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B (disorder)",15,15,15,0,0,1,1,1
440,cullin 2,25,50,25,25,0,0.5,1,1
441,Radicular Cyst,20,20,19,0,1,0.95,0.904761905,1
442,serine/threonine kinase 4,69,142,69,73,0,0.485915493,1,3
443,"Hyperalgesia, Thermal",41,41,39,0,2,0.951219512,0.906976744,0
444,RAS guanyl releasing protein 1,34,67,34,33,0,0.507462687,1,1
445,Bamforth syndrome,14,14,11,0,3,0.785714286,0.647058824,1
446,Situs ambiguus,46,46,43,0,3,0.934782609,0.87755102,1
447,CD5 molecule like,16,16,14,0,2,0.875,0.777777778,1
448,phospholipase A2 group XV,21,281,21,260,0,0.074733096,1,3
449,Malignant neoplasm of brain,208,208,198,0,10,0.951923077,0.908256881,1
450,Spinocerebellar Ataxia Type 1,178,178,144,0,34,0.808988764,0.679245283,1
451,eukaryotic translation initiation factor 4E binding protein 1,162,324,162,162,0,0.5,1,1
452,aldehyde dehydrogenase 4 family member A1,14,14,12,0,2,0.857142857,0.75,0
453,glycoprotein V platelet,13,13,11,0,2,0.846153846,0.733333333,1
454,insulin like growth factor binding protein 4,66,66,58,0,8,0.878787879,0.783783784,1
455,Russell Silver syndrome,34,68,34,34,0,0.5,1,1
456,Bloch Sulzberger syndrome,80,80,76,0,4,0.95,0.904761905,1
457,semaphorin 3D,12,12,12,0,0,1,1,1
458,pyruvic acid,57,60,57,3,0,0.95,1,1
459,"renalase, FAD dependent amine oxidase",34,34,30,0,4,0.882352941,0.789473684,1
460,interleukin 1 receptor type 2,72,72,65,0,7,0.902777778,0.82278481,2
461,"CLEFT PALATE, X-LINKED",26,26,26,0,0,1,1,1
462,metallothionein 1F,42,84,42,42,0,0.5,1,1
463,"HOMOCYSTINURIA DUE TO DEFICIENCY OF N(5,10)-METHYLENETETRAHYDROFOLATE REDUCTASE ACTIVITY",16,16,12,0,4,0.75,0.6,1
464,"Xeroderma pigmentosum, variant type",11,11,11,0,0,1,1,1
465,Wiskott-Aldrich Syndrome,279,1671,279,1392,0,0.166965889,1,4
466,"Pneumonia, Ventilator-Associated",20,20,18,0,2,0.9,0.818181818,1
467,interleukin 7,323,1160,323,837,0,0.278448276,1,6
468,Autonomic nervous system disorders,18,18,18,0,0,1,1,1
469,Chronic Cholecystitis,18,18,14,0,4,0.777777778,0.636363636,1
470,BETA THALASSEMIA TRAIT,113,113,102,0,11,0.902654867,0.822580645,1
471,acyl-CoA oxidase like,14,14,11,0,3,0.785714286,0.647058824,1
472,Idiopathic pulmonary hypertension,547,547,544,0,3,0.994515539,0.989090909,1
473,Sentinel node (disorder),60,60,55,0,5,0.916666667,0.846153846,1
474,growth differentiation factor 6,53,106,53,53,0,0.5,1,3
475,"Cirrhosis, cryptogenic",12,12,12,0,0,1,1,1
476,Familial Atypical Multiple Mole-Melanoma,16,16,16,0,0,1,1,1
477,Male infertility,809,809,809,0,0,1,1,2
478,Epithelial cyst,25,25,23,0,2,0.92,0.851851852,1
479,small ubiquitin like modifier 2,23,23,19,0,4,0.826086957,0.703703704,0
480,polybromo 1,85,170,85,85,0,0.5,1,3
481,Waardenburg Syndrome Type 2,36,36,33,0,3,0.916666667,0.846153846,1
482,Glucose Metabolism Disorders,15,15,13,0,2,0.866666667,0.764705882,1
483,Dry Eye Syndromes,64,64,59,0,5,0.921875,0.855072464,1
484,Abdominal Neoplasms,11,11,11,0,0,1,1,0
485,interferon regulatory factor 2 binding protein 2,11,22,11,11,0,0.5,1,0
486,"DEVELOPMENTAL DELAY, EPILEPSY, AND NEONATAL DIABETES",13,13,13,0,0,1,1,1
487,Cytochrome-c Oxidase Deficiency,155,155,143,0,12,0.922580645,0.856287425,0
488,Potocki-Lupski syndrome,35,47,35,12,0,0.744680851,1,1
489,"Hypertension, Renovascular",53,53,49,0,4,0.924528302,0.859649123,0
490,bleeding ulcer,12,12,11,0,1,0.916666667,0.846153846,0
491,Prostatic Hyperplasia,150,150,142,0,8,0.946666667,0.898734177,1
492,"Xanthomatosis, Cerebrotendinous",94,94,91,0,3,0.968085106,0.93814433,1
493,Acute Lung Injury,96,96,87,0,9,0.90625,0.828571429,0
494,serum/glucocorticoid regulated kinase family member 3,13,13,13,0,0,1,1,1
495,ADAM metallopeptidase with thrombospondin type 1 motif 9,66,66,60,0,6,0.909090909,0.833333333,3
496,Multiple self-healing squamous epithelioma,13,13,12,0,1,0.923076923,0.857142857,1
497,musashi RNA binding protein 2,23,23,20,0,3,0.869565217,0.769230769,3
498,serine dehydratase,289,939,289,650,0,0.307774228,1,5
499,Mental Retardation,1454,2235,1454,781,0,0.650559284,1,4
500,GRB2 associated binding protein 2,96,96,88,0,8,0.916666667,0.846153846,1
501,kelch like family member 2,28,34,28,6,0,0.823529412,1,1
502,Spina Bifida,295,314,295,19,0,0.939490446,1,1
503,"Ectodermal dysplasia, hypohidrotic, with immune deficiency",24,24,22,0,2,0.916666667,0.846153846,0
504,fasciculation and elongation protein zeta 1,40,80,40,40,0,0.5,1,3
505,glutathione S-transferase C-terminal domain containing,12,12,12,0,0,1,1,1
506,Uremia syndrome,108,108,98,0,10,0.907407407,0.830508475,1
507,Fas associated factor 1,23,23,23,0,0,1,1,0
508,Nodular Lymphocyte Predominant Hodgkin Lymphoma,14,14,11,0,3,0.785714286,0.647058824,1
509,Breast Diseases,76,76,67,0,9,0.881578947,0.788235294,1
510,Polyarteritis Nodosa,20,20,19,0,1,0.95,0.904761905,1
511,Warburg Sjo Fledelius syndrome,29,29,24,0,5,0.827586207,0.705882353,0
512,"Microangiopathy, Diabetic",14,14,11,0,3,0.785714286,0.647058824,0
513,"Hand, Foot and Mouth Disease",11,11,11,0,0,1,1,1
514,Loeys-Dietz Aortic Aneurysm Syndrome,15,15,13,0,2,0.866666667,0.764705882,2
515,Exfoliation Syndrome,184,184,170,0,14,0.923913043,0.858585859,1
516,"CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2K",16,16,16,0,0,1,1,1
517,dipeptidase 2,64,442,64,378,0,0.14479638,1,2
518,Pulmonary function,296,678,296,382,0,0.436578171,1,3
519,Anaplastic thyroid carcinoma,456,456,444,0,12,0.973684211,0.948717949,1
520,Sleep Deprivation,21,21,20,0,1,0.952380952,0.909090909,1
521,"Myopia, Degenerative",20,20,17,0,3,0.85,0.739130435,0
522,Precursor Cell Lymphoblastic Leukemia Lymphoma,3812,3812,3766,0,46,0.987932844,0.976153447,5
523,progesterone receptor,1762,4736,1762,2974,0,0.372043919,1,7
524,"Glaucoma, Open-Angle",337,337,303,0,34,0.899109792,0.81671159,1
525,TESTICULAR GERM CELL TUMOR,154,167,154,13,0,0.922155689,1,1
526,filamin A interacting protein 1 like,29,29,25,0,4,0.862068966,0.757575758,1
527,Refractive Errors,49,49,44,0,5,0.897959184,0.814814815,1
528,MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE),11,11,11,0,0,1,1,1
529,"Cystadenocarcinoma, Mucinous",18,18,17,0,1,0.944444444,0.894736842,1
530,"inositol 1,4,5-trisphosphate receptor type 1",130,1495,130,1365,0,0.086956522,1,10
531,Alveolar echinococcosis,22,22,19,0,3,0.863636364,0.76,1
532,Mitochondrial encephalopathy,11,12,11,1,0,0.916666667,1,0
533,nuclear receptor subfamily 0 group B member 2,253,418,253,165,0,0.605263158,1,2
534,Hemorrhagic Disorders,50,50,48,0,2,0.96,0.923076923,0
535,cytidine deaminase,136,501,136,365,0,0.271457086,1,3
536,"MESOMELIC DYSPLASIA, KANTAPUTRA TYPE",16,27,16,11,0,0.592592593,1,1
537,Fukuyama Type Congenital Muscular Dystrophy,107,107,99,0,8,0.925233645,0.860869565,1
538,Acromesomelic dysplasia Hunter-Thompson type,15,15,15,0,0,1,1,0
539,gap junction protein beta 3,162,162,156,0,6,0.962962963,0.928571429,0
540,interferon alpha inducible protein 27,595,595,577,0,18,0.969747899,0.941272431,1
541,Carcinoma in situ of uterine cervix,96,96,90,0,6,0.9375,0.882352941,0
542,NLR family apoptosis inhibitory protein,106,106,96,0,10,0.905660377,0.827586207,1
543,"VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1 (disorder)",176,176,167,0,9,0.948863636,0.902702703,1
544,small proline rich protein 1A,12,12,11,0,1,0.916666667,0.846153846,0
545,AKT [cytosol],12,12,12,0,0,1,1,0
546,Adrenal Cortical Adenoma,144,144,132,0,12,0.916666667,0.846153846,2
547,Lysosomal Storage Diseases,402,402,388,0,14,0.965174129,0.932692308,1
548,TNF receptor associated factor 5,20,20,17,0,3,0.85,0.739130435,1
549,Sotos' syndrome,100,100,96,0,4,0.96,0.923076923,1
550,Ectodermal dysplasia/ skin fragility syndrome,13,13,13,0,0,1,1,6
551,Angina Pectoris,56,77,56,21,0,0.727272727,1,1
552,Uterine Cancer,65,65,63,0,2,0.969230769,0.940298507,1
553,Metastatic Malignant Neoplasm to the Leptomeninges,33,33,29,0,4,0.878787879,0.783783784,0
554,Lafora Disease,164,164,157,0,7,0.957317073,0.918128655,1
555,interferon induced protein with tetratricopeptide repeats 1,19,19,19,0,0,1,1,1
556,Nuclear cataract,30,30,28,0,2,0.933333333,0.875,1
557,Kaposi Sarcoma,336,336,321,0,15,0.955357143,0.914529915,1
558,huntingtin interacting protein 1,47,126,47,79,0,0.373015873,1,1
559,"Carcinoma, Ehrlich Tumor",25,25,20,0,5,0.8,0.666666667,0
560,iron responsive element binding protein 2,47,47,41,0,6,0.872340426,0.773584906,1
561,Morphine Dependence,22,22,22,0,0,1,1,0
562,"Nephroblastomatosis, fetal ascites, macrosomia and Wilms tumor",12,12,12,0,0,1,1,1
563,WAS/WASL interacting protein family member 1,19,19,15,0,4,0.789473684,0.652173913,0
564,ZFP36 ring finger protein like 2,25,25,23,0,2,0.92,0.851851852,3
565,cyclin dependent kinase 5,166,266,145,100,21,0.545112782,0.77540107,4
566,"Lymphohistiocytosis, Hemophagocytic",319,319,308,0,11,0.965517241,0.933333333,1
567,X-Linked Lissencephaly,66,66,60,0,6,0.909090909,0.833333333,0
568,mitogen-activated protein kinase kinase 1,322,630,322,308,0,0.511111111,1,5
569,cholesteryl ester transfer protein,969,2560,969,1591,0,0.378515625,1,5
570,Nuclear non-senile cataract,28,28,23,0,5,0.821428571,0.696969697,0
571,Brody myopathy,21,21,21,0,0,1,1,1
572,Allograft Rejection,12,12,12,0,0,1,1,1
573,egl-9 family hypoxia inducible factor 1,105,105,96,0,9,0.914285714,0.842105263,0
574,Popliteal pterygium syndrome,21,35,21,14,0,0.6,1,0
575,Endocrine Gland Neoplasms,71,71,67,0,4,0.943661972,0.893333333,1
576,purine nucleoside phosphorylase,109,737,109,628,0,0.147896879,1,2
577,BMP binding endothelial regulator,39,78,39,39,0,0.5,1,0
578,Microsatellite Instability,111,111,101,0,10,0.90990991,0.834710744,0
579,Premature Ejaculation,17,17,17,0,0,1,1,0
580,aryl-hydrocarbon receptor repressor,32,64,32,32,0,0.5,1,1
581,transcription factor AP-2 beta,75,150,75,75,0,0.5,1,3
582,Hepatopulmonary Syndrome,108,108,99,0,9,0.916666667,0.846153846,0
583,Myoclonic dystonia,114,114,95,0,19,0.833333333,0.714285714,1
584,"Micronuclei, Chromosome-Defective",21,21,20,0,1,0.952380952,0.909090909,0
585,Cognition Disorders,81,81,77,0,4,0.950617284,0.905882353,0
586,"Carcinoma, Papillary",640,640,633,0,7,0.9890625,0.978361669,1
587,Glycogen storage disease type Ia,36,36,33,0,3,0.916666667,0.846153846,1
588,Abnormal mental state,40,40,40,0,0,1,1,1
589,Rheumatoid Arthritis,10004,10049,10004,45,0,0.995521942,1,9
590,Multiple Sclerosis,4570,4880,4570,310,0,0.93647541,1,6
591,family with sequence similarity 72 member B,49,49,43,0,6,0.87755102,0.781818182,0
592,Woolly hair,29,41,29,12,0,0.707317073,1,1
593,pregnancy specific beta-1-glycoprotein 5,11,22,11,11,0,0.5,1,1
594,Thoracic Neoplasms,18,18,16,0,2,0.888888889,0.8,0
595,Sporadic Breast Carcinoma,482,482,477,0,5,0.989626556,0.979466119,2
596,Familial Periodic Paralysis,48,48,44,0,4,0.916666667,0.846153846,1
597,gap junction protein alpha 8,196,196,188,0,8,0.959183673,0.921568627,1
598,Antisocial Personality Disorder,91,91,83,0,8,0.912087912,0.838383838,1
599,Female Breast Carcinoma,125,125,120,0,5,0.96,0.923076923,1
600,specific language impairment,35,59,35,24,0,0.593220339,1,1
601,Pick Disease of the Brain,926,926,912,0,14,0.98488121,0.970212766,1
602,semaphorin 6A,400,400,380,0,20,0.95,0.904761905,1
603,hydroxysteroid 11-beta dehydrogenase 1,183,187,183,4,0,0.978609626,1,1
604,Ataxia with vitamin E deficiency,49,49,46,0,3,0.93877551,0.884615385,1
605,Z-DNA binding protein 1,16,32,16,16,0,0.5,1,1
606,zinc finger homeobox 3,105,210,105,105,0,0.5,1,1
607,Non-Hereditary Clear Cell Renal Cell Carcinoma,32,32,29,0,3,0.90625,0.828571429,1
608,NLR family pyrin domain containing 7,71,71,65,0,6,0.915492958,0.844155844,1
609,cyclin T1,34,68,34,34,0,0.5,1,1
610,transforming acidic coiled-coil containing protein 3,34,34,29,0,5,0.852941176,0.743589744,1
611,C-type lectin domain family 3 member B,14,14,12,0,2,0.857142857,0.75,1
612,protein tyrosine phosphatase receptor type J,101,101,94,0,7,0.930693069,0.87037037,1
613,purine rich element binding protein A,15,15,15,0,0,1,1,0
614,interleukin 11 receptor subunit alpha,32,32,30,0,2,0.9375,0.882352941,1
615,endogenous retrovirus group K member 18,429,559,429,130,0,0.76744186,1,4
616,poly(ADP-ribose) polymerase 1,1218,1218,1200,0,18,0.985221675,0.970873786,2
617,Brain Aneurysm,11,11,11,0,0,1,1,1
618,Conventional (Clear Cell) Renal Cell Carcinoma,746,746,733,0,13,0.982573727,0.965744401,2
619,dynein axonemal light intermediate chain 1,15,15,12,0,3,0.8,0.666666667,1
620,Malignant hyperpyrexia due to anesthesia,340,340,333,0,7,0.979411765,0.959654179,1
621,Keratocystic Odontogenic Tumor,33,33,30,0,3,0.909090909,0.833333333,1
622,Central Core Myopathy (disorder),241,241,221,0,20,0.917012448,0.846743295,1
623,Inborn Errors of Metabolism,118,118,105,0,13,0.889830508,0.801526718,1
624,Salmonella infections,51,53,51,2,0,0.962264151,1,1
625,tankyrase 2,19,19,15,0,4,0.789473684,0.652173913,1
626,Juvenile dermatomyositis,62,62,60,0,2,0.967741935,0.9375,1
627,ataxin 3,545,1090,545,545,0,0.5,1,4
628,Dentinogenesis imperfecta without osteogenesis imperfecta,15,15,13,0,2,0.866666667,0.764705882,0
629,fibulin 5,102,204,102,102,0,0.5,1,4
630,Respiratory Tract Infections,144,144,102,0,42,0.708333333,0.548387097,1
631,endonuclease G,23,287,23,264,0,0.080139373,1,2
632,Kniest dysplasia,18,18,17,0,1,0.944444444,0.894736842,1
633,Orofaciodigital Syndrome I,13,13,13,0,0,1,1,0
634,cyclin dependent kinase 4,858,858,844,0,14,0.983682984,0.967889908,1
635,G protein regulated inducer of neurite outgrowth 1,27,54,27,27,0,0.5,1,1
636,Knobloch syndrome,17,17,15,0,2,0.882352941,0.789473684,0
637,"Kidney Failure, Acute",376,376,344,0,32,0.914893617,0.843137255,2
638,"ES1 protein homolog, mitochondrial;",342,342,322,0,20,0.941520468,0.889502762,1
639,endothelin converting enzyme 1,125,250,125,125,0,0.5,1,1
640,"Hearing Loss, Sudden",24,24,19,0,5,0.791666667,0.655172414,1
641,tetraspanin 12,28,56,28,28,0,0.5,1,1
642,D-glucopyranose 1-phosphate,20,20,20,0,0,1,1,0
643,Aqueous Humor Disorders,97,97,86,0,11,0.886597938,0.796296296,0
644,"von Willebrand Disease, Type 3",60,60,57,0,3,0.95,0.904761905,0
645,Werner Syndrome,237,1104,237,867,0,0.214673913,1,3
646,Hallopeau-Siemens Disease,132,132,111,0,21,0.840909091,0.725490196,1
647,Embryonal Neoplasm,47,47,43,0,4,0.914893617,0.843137255,1
648,central hypothyroidism,28,28,26,0,2,0.928571429,0.866666667,1
649,myosin light chain 7,11,11,11,0,0,1,1,0
650,protein kinase C gamma,104,511,104,407,0,0.203522505,1,3
651,Multiple Endocrine Neoplasia Type 2a,650,650,643,0,7,0.989230769,0.97869102,2
652,retinol binding protein 4,201,402,201,201,0,0.5,1,3
653,Degenerative Disorder,141,141,121,0,20,0.858156028,0.751552795,1
654,ADAM metallopeptidase with thrombospondin type 1 motif 15,12,12,11,0,1,0.916666667,0.846153846,1
655,RENAL INTERSTITIAL FIBROSIS,37,37,32,0,5,0.864864865,0.761904762,1
656,Scrub Typhus,31,31,29,0,2,0.935483871,0.878787879,0
657,Choroid Diseases,26,26,26,0,0,1,1,1
658,Multiple Sulfatase Deficiency Disease,32,32,32,0,0,1,1,1
659,"Bone Cysts, Aneurysmal",32,32,32,0,0,1,1,0
660,Coffin-Lowry syndrome,72,72,72,0,0,1,1,1
661,cystatin D,21,42,21,21,0,0.5,1,3
662,Thalassemia Intermedia,78,78,67,0,11,0.858974359,0.752808989,0
663,Dermatofibrosis lenticularis disseminata,16,16,16,0,0,1,1,0
664,diacylglycerol O-acyltransferase 2,15,384,15,369,0,0.0390625,1,4
665,Neuroleptic Malignant Syndrome,32,32,31,0,1,0.96875,0.939393939,1
666,myosin heavy chain 9,426,426,411,0,15,0.964788732,0.931972789,1
667,Primary Progressive Nonfluent Aphasia,14,14,14,0,0,1,1,1
668,"CHARCOT-MARIE-TOOTH DISEASE, TYPE 4J",12,12,12,0,0,1,1,0
669,"Neoplasms, Experimental",75,75,65,0,10,0.866666667,0.764705882,0
670,Carbamoyl-Phosphate Synthase I Deficiency Disease,30,30,29,0,1,0.966666667,0.935483871,1
671,mannose receptor C-type 1,1269,1269,1200,0,69,0.945626478,0.896860987,2
672,stabilin 1,12,24,12,12,0,0.5,1,1
673,TATA-box binding protein,225,568,225,343,0,0.396126761,1,4
674,C-type lectin domain family 4 member D,61,346,61,285,0,0.176300578,1,4
675,Periapical Periodontitis,21,21,19,0,2,0.904761905,0.826086957,1
676,Dyschromatosis universalis hereditaria,19,37,19,18,0,0.513513514,1,1
677,"5,10-Methylenetetrahydrofolate reductase deficiency",34,34,30,0,4,0.882352941,0.789473684,0
678,"Apraxia, Developmental Verbal",24,24,22,0,2,0.916666667,0.846153846,0
679,GRB2 associated binding protein 1,56,56,53,0,3,0.946428571,0.898305085,1
680,Extramedullary Plasmacytoma,12,12,11,0,1,0.916666667,0.846153846,1
681,vascular endothelial growth factor D,188,483,188,295,0,0.389233954,1,2
682,"CREBBP,EP300 [nucleoplasm]",15,15,14,0,1,0.933333333,0.875,1
683,TBC1 domain family member 7,13,606,13,593,0,0.021452145,1,2
684,Cutaneous Mastocytosis,13,13,11,0,2,0.846153846,0.733333333,1
685,sirtuin 1,852,1704,852,852,0,0.5,1,3
686,Anxiety neurosis (finding),13,13,13,0,0,1,1,0
687,glutathione S-transferase omega 2,62,124,62,62,0,0.5,1,1
688,COMPLEMENT COMPONENT 4A DEFICIENCY,13,13,10,0,3,0.769230769,0.625,0
689,"helicase, lymphoid specific",20,20,20,0,0,1,1,1
690,Atrioventricular septal defect and common atrioventricular junction,13,13,13,0,0,1,1,0
691,crystallin gamma D,225,225,212,0,13,0.942222222,0.890756303,1
692,"Anemia, Macrocytic",23,23,23,0,0,1,1,1
693,beta-Galactosidase Deficiency,19,19,19,0,0,1,1,1
694,Anhydrotic Ectodermal Dysplasias,26,26,26,0,0,1,1,1
695,"Nephrogenic Diabetes Insipidus, Type II",17,17,17,0,0,1,1,0
696,CREB regulated transcription coactivator 3,11,22,11,11,0,0.5,1,0
697,interleukin 37,87,174,87,87,0,0.5,1,3
698,Combined hyperlipidemia,21,21,15,0,6,0.714285714,0.555555556,0
699,Mainzer-Saldino Disease,13,13,13,0,0,1,1,1
700,Creatinine finding,91,91,87,0,4,0.956043956,0.915789474,1
701,Scapuloperoneal myopathy,13,18,13,5,0,0.722222222,1,1
702,Intermittent Claudication,28,28,25,0,3,0.892857143,0.806451613,1
703,Endocardial Cushion Defects,13,13,13,0,0,1,1,1
704,Papillary thyroid carcinoma,1770,1788,1770,18,0,0.989932886,1,2
705,hydroxysteroid 17-beta dehydrogenase 7,179,186,179,7,0,0.962365591,1,1
706,mitogen-activated protein kinase kinase 3,25,48,25,23,0,0.520833333,1,1
707,leucine rich repeat containing G protein-coupled receptor 5,163,163,143,0,20,0.877300613,0.781420765,1
708,basic charge Y-linked 2C,11,11,11,0,0,1,1,1
709,RNA guanine-7 methyltransferase,863,867,863,4,0,0.99538639,1,1
710,inosine monophosphate dehydrogenase 1,67,96,67,29,0,0.697916667,1,1
711,Pleomorphic Carcinoma,18,18,18,0,0,1,1,0
712,Myasthenia Gravis,482,541,482,59,0,0.890942699,1,1
713,bilateral breast cancer,71,71,66,0,5,0.929577465,0.868421053,1
714,Cerebral Small Vessel Diseases,33,33,33,0,0,1,1,1
715,Metabolic Syndrome X,2378,2378,2222,0,156,0.934398654,0.876874507,2
716,tubulin alpha 1b,35,35,32,0,3,0.914285714,0.842105263,0
717,Muscle twitch,14,14,12,0,2,0.857142857,0.75,0
718,multiple EGF like domains 10,21,21,19,0,2,0.904761905,0.826086957,1
719,Status Epilepticus,225,225,220,0,5,0.977777778,0.956521739,1
720,Monocytoid B-cell lymphoma,15,15,13,0,2,0.866666667,0.764705882,1
721,leucine rich repeats and immunoglobulin like domains 2,20,20,17,0,3,0.85,0.739130435,0
722,Harlequin Fetus,38,38,33,0,5,0.868421053,0.76744186,0
723,"46, XY female",58,58,55,0,3,0.948275862,0.901639344,0
724,Hematocrit level,57,57,52,0,5,0.912280702,0.838709677,1
725,"phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1",34,34,31,0,3,0.911764706,0.837837838,0
726,ubiquitin conjugating enzyme E2 S,57,57,53,0,4,0.929824561,0.868852459,1
727,ferritin mitochondrial,24,48,24,24,0,0.5,1,1
728,"Subfertility, Male",14,14,14,0,0,1,1,0
729,"Leukemia, Large Granular Lymphocytic",108,108,100,0,8,0.925925926,0.862068966,1
730,Aortic Diseases,37,37,37,0,0,1,1,0
731,brain dysfunction,11,11,11,0,0,1,1,1
732,protein tyrosine phosphatase non-receptor type 3,26,26,26,0,0,1,1,0
733,Advanced Malignant Neoplasm,136,136,122,0,14,0.897058824,0.813333333,1
734,drebrin like,13,13,13,0,0,1,1,1
735,Alagille Syndrome,107,125,107,18,0,0.856,1,1
736,Skin Pigmentation Disorder,12,12,12,0,0,1,1,0
737,Schizotypal Personality Disorder,13,13,13,0,0,1,1,1
738,Congenital ocular coloboma (disorder),122,122,119,0,3,0.975409836,0.952,1
739,Oppositional Defiant Disorder,39,39,33,0,6,0.846153846,0.733333333,1
740,Ovarian Serous Tumor,12,12,12,0,0,1,1,1
741,Ras protein specific guanine nucleotide releasing factor 1,110,110,100,0,10,0.909090909,0.833333333,1
742,plakophilin 2,92,184,92,92,0,0.5,1,3
743,dopachrome tautomerase,94,188,94,94,0,0.5,1,3
744,Carcinoma of unknown primary,13,13,13,0,0,1,1,1
745,actinin alpha 4,180,180,166,0,14,0.922222222,0.855670103,1
746,"Charcot-Marie-Tooth disease, X-linked, 1",107,107,107,0,0,1,1,1
747,"Pseudohypoaldosteronism, Type II",92,137,92,45,0,0.671532847,1,1
748,Stage II Colon Cancer AJCC v7,24,24,22,0,2,0.916666667,0.846153846,1
749,Color vision defect,23,23,20,0,3,0.869565217,0.769230769,1
750,TBC1 domain family member 24,52,286,52,234,0,0.181818182,1,1
751,B Lymphoblastic Lymphoma,14,14,14,0,0,1,1,1
752,Intellectual impairment,20,20,20,0,0,1,1,0
753,FXYD domain containing ion transport regulator 6,12,24,12,12,0,0.5,1,1
754,Cervical Squamous Cell Carcinoma,204,204,200,0,4,0.980392157,0.961538462,1
755,nuclear receptor subfamily 1 group H member 2,172,172,165,0,7,0.959302326,0.921787709,4
756,"Candidiasis, Chronic Mucocutaneous",71,71,65,0,6,0.915492958,0.844155844,1
757,Malignant neoplasm of gastrointestinal tract,395,395,366,0,29,0.926582278,0.863207547,1
758,PDZK1 interacting protein 1,24,48,24,24,0,0.5,1,2
759,Donohue Syndrome,91,91,91,0,0,1,1,1
760,interleukin 17D,350,700,350,350,0,0.5,1,2
761,Miller Dieker syndrome,177,177,154,0,23,0.870056497,0.77,1
762,Unipolar Depression,1331,1331,1288,0,43,0.967693464,0.937409025,2
763,ribosomal protein S2,13,346,13,333,0,0.037572254,1,3
764,calpain 2,11,21,11,10,0,0.523809524,1,1
765,Sleep Disorders,160,163,160,3,0,0.981595092,1,2
766,protein tyrosine phosphatase non-receptor type 12,40,40,34,0,6,0.85,0.739130435,1
767,"MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1B (disorder)",20,20,20,0,0,1,1,1
768,Endocrine System Diseases,122,122,112,0,10,0.918032787,0.848484848,0
769,CUGBP Elav-like family member 1,56,1525,56,1469,0,0.036721311,1,7
770,insulin dependent diabetes mellitus 7,12,12,12,0,0,1,1,0
771,ubiquitin conjugating enzyme E2 T,40,40,33,0,7,0.825,0.70212766,1
772,WHIM syndrome,54,54,52,0,2,0.962962963,0.928571429,0
773,WAGR Syndrome,53,53,53,0,0,1,1,1
774,Myelodysplastic Syndrome with Isolated del(5q),103,103,97,0,6,0.941747573,0.889908257,1
775,ribosomal protein S27,65,186,65,121,0,0.349462366,1,2
776,interferon alpha 6,12,12,12,0,0,1,1,1
777,Hereditary Motor and Sensory Neuropathies,119,119,100,0,19,0.840336134,0.724637681,1
778,Common Cold,37,37,35,0,2,0.945945946,0.897435897,1
779,myosin VB,45,90,45,45,0,0.5,1,1
780,death associated protein kinase 1,247,247,233,0,14,0.943319838,0.892720307,1
781,latent transforming growth factor beta binding protein 4,40,80,40,40,0,0.5,1,2
782,G protein-coupled receptor 151,47,94,47,47,0,0.5,1,0
783,"17,20-LYASE DEFICIENCY, ISOLATED",12,12,12,0,0,1,1,0
784,Oculocutaneous albinism type 2,42,42,42,0,0,1,1,1
785,Motion Sickness,18,18,18,0,0,1,1,0
786,"Diabetes Mellitus, Non-Insulin-Dependent",13455,13455,12999,0,456,0.966109253,0.934440371,14
787,Aortic Aneurysm,438,1569,438,1131,0,0.2791587,1,4
788,Mevalonic Aciduria,20,20,20,0,0,1,1,1
789,"GRANULOMATOUS DISEASE, CHRONIC, X-LINKED",19,19,19,0,0,1,1,1
790,interleukin 7 receptor,257,514,257,257,0,0.5,1,2
791,Xeroderma Pigmentosum Complementation Group A,106,106,99,0,7,0.933962264,0.876106195,1
792,endogenous retrovirus group W member 4,261,261,255,0,6,0.977011494,0.95505618,1
793,Intestinal Neoplasms,221,221,200,0,21,0.904977376,0.826446281,1
794,chymotrypsin C,46,92,46,46,0,0.5,1,3
795,Intervertebral disc disorder,23,23,20,0,3,0.869565217,0.769230769,1
796,TBC1 domain family member 9,1651,2223,1651,572,0,0.742690058,1,3
797,"SPHEROCYTOSIS, TYPE 4",18,18,18,0,0,1,1,1
798,syntrophin alpha 1,24,24,24,0,0,1,1,0
799,Biotinidase Deficiency,29,29,29,0,0,1,1,1
800,thrombospondin 2,101,202,101,101,0,0.5,1,3
801,Diabetes Insipidus,62,62,55,0,7,0.887096774,0.797101449,0
802,Malignant tumor of cervix,2523,2523,2400,0,123,0.951248514,0.907029478,3
803,"BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS (disorder)",37,37,31,0,6,0.837837838,0.720930233,1
804,Dermatologic disorders,824,824,800,0,24,0.970873786,0.943396226,1
805,cancer/testis antigen family 45 member A1,12,19,12,7,0,0.631578947,1,1
806,"Pseudohypoaldosteronism, Type I, Autosomal Recessive",13,13,13,0,0,1,1,1
807,Chronic Graft Versus Host Disease,150,150,133,0,17,0.886666667,0.796407186,1
808,cysteine rich secretory protein LCCL domain containing 2,14,14,14,0,0,1,1,2
809,EH domain containing 1,11,11,11,0,0,1,1,0
810,Celiac Disease,1556,1606,1556,50,0,0.96886675,1,3
811,BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY,31,31,29,0,2,0.935483871,0.878787879,1
812,"BRACHYDACTYLY, TYPE A2",27,27,25,0,2,0.925925926,0.862068966,0
813,Impaired glucose tolerance,726,726,711,0,15,0.979338843,0.95951417,1
814,endogenous retrovirus group K member 11,230,500,230,270,0,0.46,1,2
815,NADH cytochrome B5 reductase deficiency,32,32,32,0,0,1,1,0
816,ADAM metallopeptidase with thrombospondin type 1 motif 4,64,64,55,0,9,0.859375,0.753424658,1
817,Glomerulosclerosis (disorder),157,157,144,0,13,0.917197452,0.847058824,1
818,Cohen syndrome,35,35,35,0,0,1,1,0
819,"destrin, actin depolymerizing factor",15,15,15,0,0,1,1,1
820,retinol binding protein 2,24,48,24,24,0,0.5,1,1
821,Marfan Syndrome,514,522,514,8,0,0.98467433,1,1
822,Neurodegeneration with brain iron accumulation (NBIA),86,86,76,0,10,0.88372093,0.791666667,1
823,death associated protein kinase 2,33,33,33,0,0,1,1,0
824,CUGBP Elav-like family member 2,29,427,29,398,0,0.067915691,1,2
825,"Gangliosidosis, Generalized GM1, Type 2",15,15,15,0,0,1,1,1
826,glutamate receptor interacting protein 1,15,30,15,15,0,0.5,1,0
827,DOYNE HONEYCOMB RETINAL DYSTROPHY,17,17,17,0,0,1,1,0
828,phosphoribosyl pyrophosphate synthetase 1 like 1,22,22,19,0,3,0.863636364,0.76,0
829,SPINAL MUSCULAR ATROPHY WITH RESPIRATORY DISTRESS 1,38,38,35,0,3,0.921052632,0.853658537,0
830,Hemoglobin Adverse Event,14,14,11,0,3,0.785714286,0.647058824,1
831,Adrenal hypertrophy or hyperplasia,84,84,81,0,3,0.964285714,0.931034483,1
832,Marinesco-Sjogren syndrome,21,21,21,0,0,1,1,1
833,mitogen-activated protein kinase kinase 6,29,57,29,28,0,0.50877193,1,2
834,Hereditary Coproporphyria,43,43,38,0,5,0.88372093,0.791666667,0
835,marginal zone B and B1 cell specific protein,58,58,51,0,7,0.879310345,0.784615385,1
836,Hay fever,161,161,148,0,13,0.919254658,0.850574713,1
837,Colon Carcinoma,7258,7259,7000,1,258,0.964320154,0.931346461,7
838,cadherin 17,93,186,93,93,0,0.5,1,3
839,CCAAT enhancer binding protein epsilon,34,34,34,0,0,1,1,1
840,3-Methylglutaconic aciduria type 2,98,98,98,0,0,1,1,0
841,"DEAFNESS, AUTOSOMAL RECESSIVE (disorder)",47,47,47,0,0,1,1,1
842,Chronic eosinophilic leukemia,183,183,183,0,0,1,1,1
843,Multiple Endocrine Neoplasia,316,3135,316,2819,0,0.100797448,1,8
844,"Child Development Disorders, Pervasive",64,64,55,0,9,0.859375,0.753424658,1
845,Compression of spinal cord,16,16,16,0,0,1,1,1
846,"Anemia, Hemolytic",262,319,262,57,0,0.821316614,1,1
847,Cardiovascular Abnormalities,30,30,30,0,0,1,1,1
848,Dystrophia myotonica 2,12,12,12,0,0,1,1,1
849,Deficiency of glucose-6-phosphate dehydrogenase,312,312,312,0,0,1,1,2
850,multimerin 1,71,142,71,71,0,0.5,1,3
851,Guillain-Barre Syndrome,77,77,77,0,0,1,1,1
852,Axenfeld anomaly (disorder),16,16,16,0,0,1,1,1
853,desmocollin 2,96,192,96,96,0,0.5,1,2
854,MASP2 DEFICIENCY,11,11,7,0,4,0.636363636,0.466666667,1
855,AMYOTROPHIC LATERAL SCLEROSIS AND/OR FRONTOTEMPORAL DEMENTIA 1,15,15,15,0,0,1,1,0
856,Loss of scalp hair,16,16,16,0,0,1,1,1
857,Canarypox (disorder),35,35,35,0,0,1,1,0
858,LATS:p-MOB [cytosol],15,15,15,0,0,1,1,1
859,Stage III Colon Cancer AJCC v7,28,28,23,0,5,0.821428571,0.696969697,1
860,C3 and PZP like alpha-2-macroglobulin domain containing 8,73,73,73,0,0,1,1,1
861,solute carrier family 25 member 38,15,15,15,0,0,1,1,1
862,Chagas Cardiomyopathy,54,54,54,0,0,1,1,1
863,RETINAL DAMAGE,15,15,15,0,0,1,1,0
864,Hemophilia A carrier,12,12,12,0,0,1,1,1
865,glycoprotein VI platelet,87,87,87,0,0,1,1,1
866,Drug Eruptions,37,37,37,0,0,1,1,0
867,Jaw Abnormalities,11,11,11,0,0,1,1,0
868,Hepatitis B Virus-Related Hepatocellular Carcinoma,22,22,22,0,0,1,1,0
869,RNA binding motif protein X-linked,15,16,15,1,0,0.9375,1,0
870,Female Urogenital Diseases,18,18,18,0,0,1,1,0
871,dimethylarginine dimethylaminohydrolase 2,46,92,46,46,0,0.5,1,1
872,poly(rC) binding protein 4,169,338,169,169,0,0.5,1,2
873,tumor necrosis factor,11859,47701,11859,35842,0,0.24861114,1,116
874,"Dominant dystrophic epidermolysis bullosa, albopapular type (disorder)",15,15,15,0,0,1,1,1
875,Communication impairment,11,11,11,0,0,1,1,1
876,Autoimmune Diseases,3595,3597,3595,2,0,0.999443981,1,3
877,Sudden Cardiac Death,149,149,149,0,0,1,1,1
878,Infantile onset spinocerebellar ataxia,17,17,17,0,0,1,1,1
879,Infantile myofibromatosis,13,13,13,0,0,1,1,1
880,Oropharyngeal squamous cell carcinoma,91,91,88,0,3,0.967032967,0.936170213,1
881,gap junction protein gamma 2,54,54,54,0,0,1,1,1
882,Esophageal Atresia,25,31,25,6,0,0.806451613,1,1
883,cAMP responsive element modulator,75,150,75,75,0,0.5,1,3
884,"Gonadal Dysgenesis, 46,XY",37,37,37,0,0,1,1,1
885,endothelin receptor type B,402,1503,402,1101,0,0.26746507,1,5
886,cyclin dependent kinase inhibitor 1B,1285,1285,1200,0,85,0.93385214,0.875912409,2
887,Intracranial Thrombosis,29,29,29,0,0,1,1,0
888,leukocyte cell derived chemotaxin 2,22,22,22,0,0,1,1,0
889,"Nevus, Blue",17,17,17,0,0,1,1,0
890,"spinocerebellar ataxia, autosomal recessive 2",20,38,20,18,0,0.526315789,1,1
891,HMG CoA lyase deficiency,16,16,16,0,0,1,1,1
892,interleukin 15,456,1002,456,546,0,0.45508982,1,3
893,signal-induced proliferation-associated 1,60,1554,60,1494,0,0.038610039,1,7
894,Renal hypouricemia,51,51,51,0,0,1,1,1
895,calcyclin binding protein,55,110,55,55,0,0.5,1,1
896,SH3 domain binding protein 4,47,47,47,0,0,1,1,1
897,Lower respiratory tract infection,25,25,25,0,0,1,1,0
898,hydroxysteroid 17-beta dehydrogenase 13,50,50,45,0,5,0.9,0.818181818,1
899,Coronary Artery Disease,4735,4749,4735,14,0,0.997052011,1,5
900,G protein-coupled receptor class C group 5 member A,99,99,87,0,12,0.878787879,0.783783784,1
901,Renal glomerular disease,166,166,143,0,23,0.861445783,0.756613757,1
902,Liver regeneration disorder,152,152,152,0,0,1,1,1
903,splicing factor 3b subunit 2,116,578,116,462,0,0.200692042,1,2
904,FUNDUS ALBIPUNCTATUS,65,65,65,0,0,1,1,1
905,CD40 ligand,861,2020,861,1159,0,0.426237624,1,7
906,MCF.2 cell line derived transforming sequence like,50,50,44,0,6,0.88,0.785714286,1
907,Pustulosis of Palms and Soles,29,29,29,0,0,1,1,1
908,"PRECOCIOUS PUBERTY, CENTRAL",30,30,30,0,0,1,1,0
909,skin toxicity,46,46,46,0,0,1,1,1
910,"Neoplasms, Neuroepithelial",22,22,22,0,0,1,1,0
911,Progressive Neoplastic Disease,269,269,269,0,0,1,1,2
912,Hantavirus Infections,146,146,146,0,0,1,1,1
913,Sexually Transmitted Diseases,23,25,23,2,0,0.92,1,1
914,death domain associated protein,65,65,55,0,10,0.846153846,0.733333333,1
915,"actin alpha 1, skeletal muscle",136,136,121,0,15,0.889705882,0.801324503,1
916,pre T cell antigen receptor alpha,19,19,19,0,0,1,1,1
917,Corpus callosum agenesis neuronopathy,14,14,14,0,0,1,1,1
918,Prostatic Diseases,71,71,66,0,5,0.929577465,0.868421053,0
919,Neurodegenerative Disorders,2737,2737,2675,0,62,0.977347461,0.955698464,3
920,Neuroendocrine Tumors,531,531,511,0,20,0.962335217,0.927404719,1
921,"Infarction, Middle Cerebral Artery",108,108,100,0,8,0.925925926,0.862068966,1
922,lipopolysaccharide binding protein,75,150,75,75,0,0.5,1,1
923,Very Low Birth Weight,45,45,43,0,2,0.955555556,0.914893617,1
924,Benign Neoplasm,347,414,347,67,0,0.838164251,1,1
925,Gastrointestinal Stromal Tumors,1804,1804,1790,0,14,0.992239468,0.98459846,3
926,transcription factor 7 like 1,58,92,58,34,0,0.630434783,1,1
927,Anal carcinoma,27,27,25,0,2,0.925925926,0.862068966,0
928,ubiquitin conjugating enzyme E2 L3,29,29,27,0,2,0.931034483,0.870967742,1
929,Roberts-SC phocomelia syndrome,24,24,24,0,0,1,1,0
930,Pineal Gland Neoplasm,11,11,11,0,0,1,1,1
931,MUCOLIPIDOSIS II ALPHA/BETA (disorder),11,11,11,0,0,1,1,0
932,"Optic Atrophy, Hereditary, Leber",154,154,144,0,10,0.935064935,0.87804878,1
933,ribosomal protein S4 X-linked,17,17,17,0,0,1,1,1
934,phosphatidylethanolamine binding protein 4,20,20,20,0,0,1,1,0
935,serine peptidase inhibitor Kazal type 5,145,145,140,0,5,0.965517241,0.933333333,1
936,Peripheral Nerve Sheath Neoplasm,12,12,12,0,0,1,1,1
937,vesicle associated membrane protein 2,13,13,13,0,0,1,1,1
938,BCL2 like 12,63,63,63,0,0,1,1,0
939,anoctamin 3,29,58,29,29,0,0.5,1,1
940,Adenocarcinoma of lung (disorder),2336,2336,2222,0,114,0.95119863,0.906938776,3
941,Fanconi Syndrome,24,24,24,0,0,1,1,1
942,Adenosquamous carcinoma,83,83,83,0,0,1,1,1
943,Shoulder Pain,12,12,12,0,0,1,1,0
944,Developmental reading disorder,58,58,54,0,4,0.931034483,0.870967742,0
945,acyl-CoA dehydrogenase family member 9,16,16,16,0,0,1,1,1
946,childhood rhabdomyosarcoma,34,34,34,0,0,1,1,1
947,Mouth Diseases,22,22,12,0,10,0.545454545,0.375,1
948,Migraine with Aura,180,244,180,64,0,0.737704918,1,1
949,HOLOPROSENCEPHALY 3,15,15,15,0,0,1,1,0
950,Congenital Thrombotic Thrombocytopenic Purpura,77,77,67,0,10,0.87012987,0.770114943,1
951,Wolcott-Rallison syndrome,43,43,40,0,3,0.930232558,0.869565217,1
952,heterogeneous nuclear ribonucleoprotein D like,44,44,40,0,4,0.909090909,0.833333333,1
953,melanin concentrating hormone receptor 1,52,52,50,0,2,0.961538462,0.925925926,1
954,Guanidinoacetate methyltransferase deficiency,13,13,13,0,0,1,1,1
955,Familial hyperparathyroidism,27,27,27,0,0,1,1,1
956,neurexophilin 1,28,56,28,28,0,0.5,1,2
957,Hyperimmunoglobulinemia D,49,49,43,0,6,0.87755102,0.781818182,1
958,microRNA 18a,20,40,20,20,0,0.5,1,0
959,Cartilage Diseases,12,12,12,0,0,1,1,1
960,coactosin like F-actin binding protein 1,29,29,29,0,0,1,1,1
961,periodic paralysis (finding),40,40,37,0,3,0.925,0.860465116,1
962,Rectal Polyp,11,11,11,0,0,1,1,0
963,Porphobilinogen synthase deficiency,21,21,21,0,0,1,1,2
964,"Mammary Neoplasms, Experimental",271,271,266,0,5,0.981549815,0.963768116,1
965,Trigeminal Neuralgia,40,40,35,0,5,0.875,0.777777778,1
966,"Familial Amyloid Polyneuropathy, Type V",33,33,33,0,0,1,1,0
967,EDAR associated death domain,34,34,34,0,0,1,1,1
968,Intraocular pressure disorder,173,173,173,0,0,1,1,1
969,NEPHRONOPHTHISIS 2,11,11,11,0,0,1,1,1
970,MPS III B,47,47,47,0,0,1,1,1
971,peroxisome proliferator activated receptor alpha,779,779,764,0,15,0.980744544,0.962216625,1
972,Insulin Sensitivity,12,12,12,0,0,1,1,0
973,GIANT AXONAL NEUROPATHY 1,34,34,22,0,12,0.647058824,0.47826087,1
974,Adult Acute Lymphocytic Leukemia,210,210,210,0,0,1,1,1
975,phospholipase A2 group VI,379,639,379,260,0,0.593114241,1,2
976,Blood pressure finding,489,489,489,0,0,1,1,1
977,interleukin 1 receptor type 1,272,272,272,0,0,1,1,1
978,Acute Chest Syndrome,18,18,18,0,0,1,1,1
979,integrin binding sialoprotein,145,145,145,0,0,1,1,1
980,psychological symptom,16,16,16,0,0,1,1,0
981,PAXIP1 associated glutamate rich protein 1,60,60,60,0,0,1,1,2
982,insulin like growth factor binding protein 7,255,255,255,0,0,1,1,1
983,Dysplastic Nevus,98,119,98,21,0,0.823529412,1,1
984,Low-density lipoprotein receptor,12,10524,12,10512,0,0.001140251,1,20
985,"Alzheimer disease, familial, type 3",34,34,34,0,0,1,1,1
986,C-terminal binding protein 2,47,94,47,47,0,0.5,1,3
987,RAD54 like,28,29,28,1,0,0.965517241,1,0
988,adhesion G protein-coupled receptor V1,64,64,64,0,0,1,1,1
989,"Corneal Dystrophy, Juvenile Epithelial of Meesmann",35,35,33,0,2,0.942857143,0.891891892,1
990,TNF receptor-associated factor 1,13,399,13,386,0,0.032581454,1,5
991,Conduct Disorder,82,83,82,1,0,0.987951807,1,1
992,monocyte to macrophage differentiation associated,25,28,25,3,0,0.892857143,1,1
993,growth differentiation factor 2,48,96,48,48,0,0.5,1,0
994,beta Thalassemia,1056,1237,1056,181,0,0.853678254,1,2
995,Q Fever,34,34,29,0,5,0.852941176,0.743589744,0
996,MLX interacting protein like,72,72,67,0,5,0.930555556,0.87012987,0
997,metastasis associated 1 family member 3,36,36,29,0,7,0.805555556,0.674418605,1
998,MPS III C,13,13,11,0,2,0.846153846,0.733333333,0
999,ubiquilin 2,66,132,66,66,0,0.5,1,14
1000,calpain small subunit 1,22,529,22,507,0,0.041587902,1,3
